CD59 and obstructive sleep apnea syndrome: S5), statins may reduce cholesterol biosynthesis and thus reverse increased cholesterol-enriched plasma membrane domain formation and endocytosis of endothelial CD59, thereby preserving protection against complement activity in OSA.